Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantation

被引:0
|
作者
Yanagisawa, Ryu [1 ]
Koyama, Hiroaki [2 ]
Yakushijin, Kimikazu [3 ]
Uchida, Naoyuki [4 ]
Jinguji, Atsushi [5 ]
Takeda, Wataru [6 ]
Nishida, Tetsuya [7 ]
Tanaka, Masatsugu [8 ]
Eto, Tetsuya [9 ]
Ohigashi, Hiroyuki [10 ]
Ikegame, Kazuhiro [11 ]
Matsuoka, Ken-ichi [12 ]
Katayama, Yuta [13 ,14 ]
Kanda, Yoshinobu [15 ]
Sawa, Masashi [16 ]
Kawakita, Toshiro [17 ]
Onizuka, Makoto [18 ]
Fukuda, Takahiro [6 ]
Atsuta, Yoshiko [19 ,20 ]
Shinohara, Akihito [2 ]
Nakasone, Hideki [15 ,21 ]
机构
[1] Shinshu Univ Hosp, Div Blood Transfus, Matsumoto, Japan
[2] Tokyo Womens Med Univ, Dept Hematol, Tokyo, Japan
[3] Kobe Univ Hosp, Dept Med Oncol & Hematol, Kobe, Japan
[4] Toranomon Gen Hosp, Dept Hematol, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Tokyo, Japan
[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, Tokyo, Japan
[6] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan
[7] Nagoya Daiichi Hosp, Japanese Red Cross Aichi Med Ctr, Dept Hematol, Nagoya, Japan
[8] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Japan
[9] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan
[10] Hokkaido Univ Hosp, Dept Hematol, Sapporo, Japan
[11] Hyogo Med Univ Hosp, Dept Hematol, Nishinomiya, Japan
[12] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan
[13] Hiroshima Red Cross Hosp, Dept Hematol, Hiroshima, Japan
[14] Atom Bomb Survivors Hosp, Hiroshima, Japan
[15] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan
[16] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Japan
[17] Natl Hosp Org, Kumamoto Med Ctr, Dept Hematol, Kumamoto, Japan
[18] Tokai Univ, Dept Hematol & Oncol, Sch Med, Isehara, Japan
[19] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagakute, Japan
[20] Aichi Med Univ, Sch Med, Dept Registry Sci Transplant & Cellular Therapy, Nagakute, Japan
[21] Jichi Med Univ, Ctr Mol Med, Div Emerging Med Integrated Therapeut, Shimotsuke, Japan
关键词
CHRONIC KIDNEY-DISEASE; LONG-TERM SURVIVORS; COMORBIDITY INDEX; INJURY; HCT; IMPACT; PATHOGENESIS; DYSFUNCTION; MORTALITY; GVHD;
D O I
10.1038/s41409-023-02172-4
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Various complications can influence hematopoietic cell transplantation (HCT) outcomes. Renal complications can occur during the early to late phases of HCT along with various factors. However, studies focusing on fatal renal complications (FRCs) are scarce. Herein, we analyzed 36,596 first allogeneic HCT recipients retrospectively. Overall, 782 patients died of FRCs at a median of 108 (range, 0-3,440) days after HCT. The cumulative incidence of FRCs was 1.7% and 2.2% at one and five years, respectively. FRCs were associated with older age, male sex, non-complete remission (non-CR), lower performance status (PS), and HCT comorbidity index (HCT-CI) associated with renal comorbidity in multivariate analysis. The risk factors within 100 days included older age, multiple myeloma, PS, and HCT-CI comorbidities (psychiatric disturbance, hepatic disease, obesity, and renal disease). Older age and male sex were risk factors between 100 days and one year. After one year, HCT-CI was associated with the presence of diabetes and prior solid tumor; total body irradiation was identified as a risk factor. Non-CR was a common risk factor in all three phases. Furthermore, acute and chronic graft-versus-host disease, reactivation of cytomegalovirus, and relapse of underlying disease also affected FRCs. Systematic follow-up may be necessary based on the patients' risk factors and post-HCT events.
引用
收藏
页码:325 / 333
页数:9
相关论文
共 50 条
  • [31] Risk Factors of Cytomegalovirus Retinitis Occurrence After Allogeneic Hematopoietic Stem Cell Transplantation
    Zhang, Hai-Qing
    Feng, Jing-Hong
    Li, Sheng-Jun
    Yang, Yun-Xian
    Long, Yan
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2025, 33 (02) : 295 - 302
  • [32] Risk factors of menopause after allogeneic hematopoietic cell transplantation in premenopausal adult women
    Lee, Yoo Jin
    Kim, Jeong Sook
    Jo, Jae-Cheol
    Kim, Youjin
    Im, Hyeon-Soo
    Kim, Hyeyeong
    Koh, SuJin
    Min, Young Joo
    Park, Sang-Hyuk
    Ahn, Jun Woo
    Choi, Yunsuk
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (03) : 449 - 457
  • [33] Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors
    Alcazer, Vincent
    de Latour, Regis Peffault
    Ader, Florence
    Labussiere-Wallet, Helene
    BULLETIN DU CANCER, 2019, 106 (06) : 574 - 583
  • [34] Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation
    Na, K-S
    Yoo, Y-S
    Mok, J. W.
    Lee, J. W.
    Joo, C-K
    BONE MARROW TRANSPLANTATION, 2015, 50 (11) : 1459 - 1464
  • [35] Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation
    K-S Na
    Y-S Yoo
    J W Mok
    J W Lee
    C-K Joo
    Bone Marrow Transplantation, 2015, 50 : 1459 - 1464
  • [36] Incidence and Risk Factors for Nontuberculous Mycobacterial Infection after Allogeneic Hematopoietic Cell Transplantation
    Beswick, Jennifer
    Shin, Elizabeth
    Michelis, Fotios V.
    Thyagu, Santhosh
    Viswabandya, Auro
    Lipton, Jeffrey H.
    Messner, Hans
    Marras, Theodore K.
    Kim, Dennis
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (02) : 366 - 372
  • [37] Incidence and Risk Factors for Nontuberculous Mycobacteria Infection after Allogeneic Hematopoietic Cell Transplantation
    Beswick, Jennifer M.
    Shin, Elizabeth
    Uhm, Jieun
    Michelis, Fotios V.
    Viswabandya, Auro
    Lipton, Jeffrey H.
    Messner, Hans A.
    Marras, Theodore
    Kim, Dennis Dong Hwan
    BLOOD, 2015, 126 (23)
  • [38] RISK FACTORS FOR BLOOD STREAM INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN
    Sajiki, Daichi
    Muramatsu, Hideki
    Wakamatsu, Manabu
    Narita, Kotaro
    Kataoka, Shinsuke
    Taniguchi, Rieko
    Narita, Atsushi
    Nishio, Nobuhiro
    Takahashi, Yoshiyuki
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [39] Risk Factors for Early Relapse after Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome
    Patel, Sagar S.
    Hamilton, Betty K.
    Rybicki, Lisa
    Thomas, Dawn
    Emrick, Arden
    Nazha, Aziz
    Mukherjee, Sudipto
    Advani, Anjali S.
    Carraway, Hetty
    Pohlman, Brad
    Bolwell, Brian
    Dean, Robert M.
    Gerds, Aaron T.
    Hanna, Rabi
    Kalaycio, Matt E.
    Zhang, Aiwen
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw
    Majhail, Navneet S.
    Askar, Medhat Z.
    Sobecks, Ronald M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [40] Risk factors associated with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation
    Shen, Biao
    Ma, Yueshen
    Zhang, Haixiao
    Wang, Mingyang
    Liu, Jia
    Cao, Jiaxin
    Guo, Wenwen
    Feng, Dan
    Yang, Donglin
    Zhang, Rongli
    Chen, Xin
    Ma, Qiaoling
    Zhai, Weihua
    Feng, Sizhou
    Han, Mingzhe
    Pang, Aiming
    Jiang, Erlie
    BLOOD SCIENCE, 2022, 4 (02): : 83 - 88